Close Menu

The New York Times reports on concerns in the biomedical community about what to do as our ability to detect tumors improves -- to the point where even the slightest number of cancerous cells will send up the alarm. As genomic tests advance, sensitivity will only increase -- but what does that mean for patients who may be treated for cancer when really they're quite healthy? From the article:

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.